Taking L-arginine pills can raise the level of arginine in your blood, but that doesn’t always mean you’ll produce more nitric oxide or get better at exercising—sometimes it helps, sometimes it...
Claim Context
Oral L-arginine supplementation increases plasma arginine concentration but fails to consistently elevate nitric oxide bioavailability or improve exercise performance in healthy or athletic populations.
The claim uses 'increases' (definitive for plasma arginine) but pairs it with 'fails to consistently elevate' and 'improve'—the word 'consistently' introduces uncertainty, making the overall language probabilistic rather than definitive or purely associative.
“L argonine levels in the blood go up that hasn't reliably translated to improved athletic performance or raised nitric oxide levels.”
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
Evidence from Studies
Supporting (4)
Community contributions welcome
L-arginine Supplementation Does Not Enhance Anaerobic Performance in Trained Female Handball Players
No effect of short-term arginine supplementation on nitric oxide production, metabolism and performance in intermittent exercise in athletes.
The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure
Contradicting (2)
Community contributions welcome
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
In healthy and athletic adults, compare plasma arginine levels, nitric oxide bioavailability (via biomarkers like nitrite/nitrate or flow-mediated dilation), and exercise performance (e.g., VO2 max, time-to-exhaustion) after 4–8 weeks of daily oral L-arginine (e.g., 6–10 g/day) versus placebo, with washout periods between conditions.
Randomized, double-blind, placebo-controlled crossover trial with 30–50 participants (healthy and athletic adults), 4–8 weeks of daily oral L-arginine (6–10 g/day) vs. placebo, with washout periods, measuring plasma arginine, nitrite/nitrate, and exercise performance endpoints at baseline, mid-point, and endpoint.
Compare the effects of 8 weeks of daily oral L-arginine (6–10 g/day) versus placebo on plasma arginine, nitric oxide bioavailability, and endurance performance in a cohort of trained athletes, with pre- and post-intervention testing under standardized conditions.
Randomized, double-blind, parallel-group RCT with 60–80 participants (healthy and athletic adults), 8 weeks of daily oral L-arginine (6–10 g/day) vs. placebo, measuring plasma arginine, plasma nitrite/nitrate, and exercise performance (e.g., cycling time trial) at baseline and endpoint.
Determine whether different doses of oral L-arginine (e.g., 2 g, 6 g, 10 g/day) produce graded increases in plasma arginine and whether these correlate with changes in nitric oxide bioavailability and exercise performance over 4 weeks.
Randomized, double-blind, dose-response RCT with 4 arms (placebo, 2g, 6g, 10g L-arginine/day) in 40–60 healthy and athletic adults, 4-week intervention, measuring plasma arginine, nitrite/nitrate, and exercise performance at baseline and weekly.
Assess whether the effects of L-arginine on nitric oxide and performance differ between sedentary, recreationally active, and elite athletic populations.
Randomized, double-blind, placebo-controlled trial with 100 participants stratified into three groups (sedentary, recreationally active, elite athletes), 6 weeks of 6 g/day L-arginine or placebo, measuring plasma arginine, nitric oxide biomarkers, and sport-specific performance outcomes.
Examine acute (single-dose) and short-term (7-day) changes in plasma arginine, nitric oxide metabolites, and vascular function after L-arginine ingestion in healthy adults to determine if plasma increases translate to functional changes.
Single-center, randomized, placebo-controlled, crossover study with 20–30 healthy adults, comparing acute (single 10g dose) and 7-day daily (10g/day) L-arginine on plasma arginine, plasma nitrite/nitrate, and flow-mediated dilation at 0, 1, 2, 4, and 24 hours post-dose.